Nuzenio

Revtorpyk

Revtorpyk news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:44:26 GMTFDA Green-Lights Five New Treatment Options for Breast Cancer - Cancer HealthCancer Health · Mon, 03 Aug 2026 13:01:12 GMTIs REVTORPYK’s First‑in‑Class FDA Approval Reframing the Investment Case For Celcuity (CELC)? - webull.comwebull.com · Mon, 03 Aug 2026 06:22:36 GMTNewly FDA-approved Revtorpyk wins NCCN listing - The Pharma LetterThe Pharma Letter · Sat, 01 Aug 2026 14:27:59 GMTNewly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer - finance.yahoo.comfinance.yahoo.com · Thu, 30 Jul 2026 12:30:00 GMTFDA Approves Revtorpyk for a Breast Cancer Subgroup That Had Been Left Out of Targeted Treatment - Medical DailyMedical Daily · Mon, 27 Jul 2026 11:50:10 GMT

Timeline

Thu, 06 Aug 2026 12:44:26 GMTCelcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call - The Manila Times
Mon, 03 Aug 2026 13:01:12 GMTFDA Green-Lights Five New Treatment Options for Breast Cancer - Cancer Health
Mon, 03 Aug 2026 06:22:36 GMTIs REVTORPYK’s First‑in‑Class FDA Approval Reframing the Investment Case For Celcuity (CELC)? - webull.com
Sat, 01 Aug 2026 14:27:59 GMTNewly FDA-approved Revtorpyk wins NCCN listing - The Pharma Letter
Thu, 30 Jul 2026 12:30:00 GMTNewly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer - finance.yahoo.com
Mon, 27 Jul 2026 11:50:10 GMTFDA Approves Revtorpyk for a Breast Cancer Subgroup That Had Been Left Out of Targeted Treatment - Medical Daily

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Revtorpyk.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.